General
Preferred name
AM404
Synonyms
AM 404 ()
AM-404 ()
P&D ID
PD003151
CAS
198022-70-7
183718-77-6
Tags
available
drug candidate
Drug indication
Discovery agent
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION A bioactive metabolite of that is proposed to mediate the central antinociceptive effects of the drug . (GtoPdb)
DESCRIPTION Anandamide transport inhibitor (Tocriscreen Total)
DESCRIPTION AM404 is an endocannabinoid reuptake inhibitor, a TRPV(1) activator, a paracetamol metabolite, with neuroprotective and anticancer activity that blocks anandamide transport. AM404 inhibits NFAT and NF-kappaB signaling pathways and impairs migration and invasiveness of neuroblastoma cells, preventing prostaglandin synthesis in activated microglia by inhibiting COX activity. (TargetMol Bioactive Compound Library)
Cell lines
1
Organisms
3
Compound Sets
8
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugMAP
Guide to Pharmacology
NIH Clinical Collections (NCC)
Probe Miner (suitable probes)
TargetMol Bioactive Compound Library
Tocriscreen Total
External IDs
49
Properties
(calculated by RDKit )
Molecular Weight
395.28
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
15
Ring Count
1
Aromatic Ring Count
1
cLogP
7.48
TPSA
49.33
Fraction CSP3
0.42
Chiral centers
0.0
Largest ring
6.0
QED
0.18
Structural alerts
2
aggregator (Aggregator Advisor)
Aggregators
aggregator (ZINC)
Aggregators
Custom attributes
(extracted from source data)
Target
TRPV1
Endocannabinoid reuptake
CNR1, CNR2, FAAH, TRPV1
MOA
cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist
Pathway
GPCR/G protein
Membrane Transporter/Ion Channel
Source data